Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Gender-dependent HLA-DR-restricted epitopes identified from herpes simplex virus type 1 glycoprotein D.

Zhang X, Castelli FA, Zhu X, Wu M, Maillère B, BenMohamed L.

Clin Vaccine Immunol. 2008 Sep;15(9):1436-49. doi: 10.1128/CVI.00123-08. Epub 2008 Jul 30.

3.

A novel HLA (HLA-A*0201) transgenic rabbit model for preclinical evaluation of human CD8+ T cell epitope-based vaccines against ocular herpes.

Chentoufi AA, Dasgupta G, Christensen ND, Hu J, Choudhury ZS, Azeem A, Jester JV, Nesburn AB, Wechsler SL, BenMohamed L.

J Immunol. 2010 Mar 1;184(5):2561-71. doi: 10.4049/jimmunol.0902322. Epub 2010 Feb 1.

4.

HLA-A*0201-restricted CD8+ cytotoxic T lymphocyte epitopes identified from herpes simplex virus glycoprotein D.

Chentoufi AA, Zhang X, Lamberth K, Dasgupta G, Bettahi I, Nguyen A, Wu M, Zhu X, Mohebbi A, Buus S, Wechsler SL, Nesburn AB, BenMohamed L.

J Immunol. 2008 Jan 1;180(1):426-37.

5.

Immunodominant epitopes in herpes simplex virus type 2 glycoprotein D are recognized by CD4 lymphocytes from both HSV-1 and HSV-2 seropositive subjects.

Kim M, Taylor J, Sidney J, Mikloska Z, Bodsworth N, Lagios K, Dunckley H, Byth-Wilson K, Denis M, Finlayson R, Khanna R, Sette A, Cunningham AL.

J Immunol. 2008 Nov 1;181(9):6604-15.

6.

Identification of novel immunodominant CD4+ Th1-type T-cell peptide epitopes from herpes simplex virus glycoprotein D that confer protective immunity.

BenMohamed L, Bertrand G, McNamara CD, Gras-Masse H, Hammer J, Wechsler SL, Nesburn AB.

J Virol. 2003 Sep;77(17):9463-73.

7.

Asymptomatic HLA-A*02:01-restricted epitopes from herpes simplex virus glycoprotein B preferentially recall polyfunctional CD8+ T cells from seropositive asymptomatic individuals and protect HLA transgenic mice against ocular herpes.

Dervillez X, Qureshi H, Chentoufi AA, Khan AA, Kritzer E, Yu DC, Diaz OR, Gottimukkala C, Kalantari M, Villacres MC, Scarfone VM, McKinney DM, Sidney J, Sette A, Nesburn AB, Wechsler SL, BenMohamed L.

J Immunol. 2013 Nov 15;191(10):5124-38. doi: 10.4049/jimmunol.1301415. Epub 2013 Oct 7.

8.

Human Asymptomatic Epitopes Identified from the Herpes Simplex Virus Tegument Protein VP13/14 (UL47) Preferentially Recall Polyfunctional Effector Memory CD44high CD62Llow CD8+ TEM Cells and Protect Humanized HLA-A*02:01 Transgenic Mice against Ocular Herpesvirus Infection.

Srivastava R, Khan AA, Garg S, Syed SA, Furness JN, Vahed H, Pham T, Yu HT, Nesburn AB, BenMohamed L.

J Virol. 2017 Jan 3;91(2). pii: e01793-16. doi: 10.1128/JVI.01793-16. Print 2017 Jan 15.

9.

Asymptomatic human CD4+ cytotoxic T-cell epitopes identified from herpes simplex virus glycoprotein B.

Chentoufi AA, Binder NR, Berka N, Durand G, Nguyen A, Bettahi I, Maillère B, BenMohamed L.

J Virol. 2008 Dec;82(23):11792-802. doi: 10.1128/JVI.00692-08. Epub 2008 Sep 17.

10.

Protective immunity against ocular herpes infection and disease induced by highly immunogenic self-adjuvanting glycoprotein D lipopeptide vaccines.

Bettahi I, Nesburn AB, Yoon S, Zhang X, Mohebbi A, Sue V, Vanderberg A, Wechsler SL, BenMohamed L.

Invest Ophthalmol Vis Sci. 2007 Oct;48(10):4643-53.

PMID:
17898288
11.

HLA-A02:01-restricted epitopes identified from the herpes simplex virus tegument protein VP11/12 preferentially recall polyfunctional effector memory CD8+ T cells from seropositive asymptomatic individuals and protect humanized HLA-A*02:01 transgenic mice against ocular herpes.

Srivastava R, Khan AA, Spencer D, Vahed H, Lopes PP, Thai NT, Wang C, Pham TT, Huang J, Scarfone VM, Nesburn AB, Wechsler SL, BenMohamed L.

J Immunol. 2015 Mar 1;194(5):2232-48. doi: 10.4049/jimmunol.1402606. Epub 2015 Jan 23.

12.

Laser Adjuvant-Assisted Peptide Vaccine Promotes Skin Mobilization of Dendritic Cells and Enhances Protective CD8+ TEM and TRM Cell Responses against Herpesvirus Infection and Disease.

Lopes PP, Todorov G, Pham TT, Nesburn AB, Bahraoui E, BenMohamed L.

J Virol. 2018 Mar 28;92(8). pii: e02156-17. doi: 10.1128/JVI.02156-17. Print 2018 Apr 15.

13.

Functional characterization of ocular-derived human alphaherpesvirus cross-reactive CD4 T cells.

Ouwendijk WJ, Geluk A, Smits SL, Getu S, Osterhaus AD, Verjans GM.

J Immunol. 2014 Apr 15;192(8):3730-9. doi: 10.4049/jimmunol.1302307. Epub 2014 Mar 12.

14.

Phenotypic and functional characterization of herpes simplex virus glycoprotein B epitope-specific effector and memory CD8+ T cells from symptomatic and asymptomatic individuals with ocular herpes.

Khan AA, Srivastava R, Spencer D, Garg S, Fremgen D, Vahed H, Lopes PP, Pham TT, Hewett C, Kuang J, Ong N, Huang L, Scarfone VM, Nesburn AB, Wechsler SL, BenMohamed L.

J Virol. 2015 Apr;89(7):3776-92. doi: 10.1128/JVI.03419-14. Epub 2015 Jan 21.

16.

A Herpes Simplex Virus Type 1 Human Asymptomatic CD8+ T-Cell Epitopes-Based Vaccine Protects Against Ocular Herpes in a "Humanized" HLA Transgenic Rabbit Model.

Srivastava R, Khan AA, Huang J, Nesburn AB, Wechsler SL, BenMohamed L.

Invest Ophthalmol Vis Sci. 2015 Jun;56(6):4013-28. doi: 10.1167/iovs.15-17074.

17.

Design and evaluation of a multi-epitope assembly peptide (MEAP) against herpes simplex virus type 2 infection in BALB/c mice.

Wang X, Xie G, Liao J, Yin D, Guan W, Pan M, Li J, Li Y.

Virol J. 2011 May 16;8:232. doi: 10.1186/1743-422X-8-232.

18.

Prophylactic herpes simplex virus type 2 vaccine adjuvanted with a universal CD4 T cell helper peptide induces long-term protective immunity against lethal challenge in mice.

Li X, Zhang S, Lei J, Zhu Y, Zhou X, Xiao J, Xiang T.

Int Immunopharmacol. 2018 Aug;61:100-108. doi: 10.1016/j.intimp.2018.05.024. Epub 2018 May 29.

PMID:
29857239
19.

Screening of human tumor antigens for CD4 T cell epitopes by combination of HLA-transgenic mice, recombinant adenovirus and antigen peptide libraries.

Osen W, Soltek S, Song M, Leuchs B, Steitz J, Tüting T, Eichmüller SB, Nguyen XD, Schadendorf D, Paschen A.

PLoS One. 2010 Nov 30;5(11):e14137. doi: 10.1371/journal.pone.0014137.

20.

Herpes simplex virus antigens directly activate NK cells via TLR2, thus facilitating their presentation to CD4 T lymphocytes.

Kim M, Osborne NR, Zeng W, Donaghy H, McKinnon K, Jackson DC, Cunningham AL.

J Immunol. 2012 May 1;188(9):4158-70. doi: 10.4049/jimmunol.1103450. Epub 2012 Mar 30.

Supplemental Content

Support Center